Log In
Print
BCIQ
Print
Print this Print this
 

Asacol, mesalazine (Z-206)

  Manage Alerts
Collapse Summary General Information
Company Zeria Pharmaceutical Co. Ltd.
DescriptionPH dependent controlled-release formulation of mesalazine
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today